Biomedical Excellence for Safer Transfusion
  • Biomedical Excellence for Safer Transfusion (BEST)
    Biomedical Excellence for Safer Transfusion (BEST)

    BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best…

  • BEST Membership
    BEST Membership

    The BEST collaborative is a unique free-standing group of over 170 manufacturers, clinicians, and scientists from 22 countries committed to improving transfusion…

  • BEST Meetings
    BEST Meetings

    BEST meetings are held twice per year. and attendance is open to all members. Invited guests may attend with pre-approval of the Chair.

  • Press Releases
    Press Releases

    Official notices regarding significant publications, special events, and member news.

  • Recommended Procedures
    Recommended Procedures

    Several best practice documents are available for download

  • Sponsorship

    Any commercial organization or Blood Service interested in advancing the purpose of BEST may become a supporter of BEST by paying the annual dues amount; providing a…

Latest News

BEST 30th Anniversary Symposium

Symposium Recording Now Available for Viewing

Call for Scott Murphy Memorial Lecture Applications

Applications for April 2022 are being accepted now thru January 17, 2022

Press Release 13 Oct 2021

Award Recipient of 27th Scott Murphy Memorial Award Lectureship Announced

Member News

  • The BEST 30th Anniversary Symposium was held on Zoom on Saturday November 6th, 2021. The Meeting Recording is now available for viewing. You must complete the access form HERE to obtain the password. 
  • Meeting presentations from BEST 62 in Marina del Rey have been posted in the Members area. Recordings will be available at a later date.
  • In the coming weeks, all BEST Members will be receiving a Non-Disclosure Agreement, which will be required annually going forward. Please contact the BEST Executive Office if you have questions.
  • Please be sure to keep your contact information on the website up to date so you can be assured of receiving our email updates.

Fall 2021

30th Anniversary

BEST 30th Anniversary Celebration Symposium

This symposium was held Saturday, 06 November 2021.
Important Details:

  • The meeting recording is now available. You must complete the access form HERE to obtain the password. 
  • Presentation slides are available to BEST Members only, in the Members area of this website.
  • The Symposium highlighted the past, present, and future of BEST and the Transfusion Medicine industry, as well as the 27th Scott Murphy Memorial Award Lecture.


Spring 2022



The Spring 2022 Meeting is planned for Warsaw, Poland 22-23 April 2022.

Important News

  • We plan to hold the meeting in the Hotel Bristol with the BEST Dinner at the Royal Castle
  • Due to the continuing COVID-19 pandemic, we have no further details at this time.



The Cellular Therapy Team 

Members of this team work at leading institutions in North America, Europe, Australia, and Asia. Key objectives of the team are to survey current practice in the preparation, assessment, storage and distribution of cellular therapy products and to perform detailed laboratory studies in selected areas of interest. 

Recent and current studies include:

  • Interlaboratory proficiency testing of cord blood stem cell collections
  • Intra and interlaboratory proficiency testing of dendritic cell products for immunotherapy protocols
  • Assessment of stem cell storage and transportation aiming to define best practice
  • Understanding the key release criteria for cellular therapy products
  • Standardization of colony forming units and other key parameters for the assessment of hematopoietic stem cells
  • Measurement of viability of cellular therapy products

The BEST cellular therapy team works closely with international organizations such as AABB, ISCT and EBMT in surveying current practice and its laboratory-based projects are conducted by expert scientists at leading institutions around the world. The results of all studies are published in leading scientific journals such as Transfusion and Cytotherapy. A list of recent publications is to be found on the website. We are keen to continue to forge new scientific links with researchers in other leading academic organizations and with key manufacturers of products used in the field of cellular therapy. We are committed to expanding our interests further into the fields of immunotherapy and regenerative medicine as these are developed for clinical study and subsequent routine application in specific patient groups. We hope that you share our belief that the horizons of cellular therapy are ever-expanding.

The team leaders for Cell Therapy are David McKenna, MD, University of Minnesota, US and David Stroncek, National Institutes of Health, US.